- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05722002
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial (CARES)
This trial is being completed to compare two commonly used options to treat pain after surgery. Participants that undergo gallbladder removal, hernia repair, and breast lump removal will be eligible to enroll. Eligible participants will be randomized to 1 of 2 groups of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) plus acetaminophen or low dose opioids plus acetaminophen).
It is anticipated that the NSAID group will have superior clinical outcomes and fewer side effects when compared to the opioid group.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Kendall Dubois, MS
- Phone Number: 734-232-0324
- Email: kendalld@med.umich.edu
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada
- Not yet recruiting
- Unity Health Toronto
-
Contact:
- Janneth P Canizares
- Phone Number: 416-864-6060
- Email: janneth.pazmino-canizares@unityhealth.to
-
Principal Investigator:
- Karim Ladha, MD, MSc, FRCPC
-
-
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Recruiting
- University of Michigan
-
Principal Investigator:
- Mark Bicket, MD, PhD
-
Contact:
- Kendall Dubois
- Phone Number: 734-232-0324
- Email: kendalld@med.umich.edu
-
Detroit, Michigan, United States, 48202
- Not yet recruiting
- Henry Ford Health System
-
Contact:
- Kelly Marsack
- Phone Number: 313-916-2600
- Email: kmarsac1@hfhs.org
-
Principal Investigator:
- Kellie McFarlin, MD, FACS
-
-
Missouri
-
Saint Louis, Missouri, United States, 63130
- Not yet recruiting
- Washington University in Saint Louis
-
Contact:
- Justin Stout, PhD, MSc
- Phone Number: 314-273-2455
- Email: justinjstout@wustl.edu
-
Principal Investigator:
- Simon Haroutounian, PhD, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- No significant analgesic medication use before surgery: For this study, significant analgesic medication use before surgery as use of prescriptions for opioid or NSAID medications in the past 30 days, or over-the-counter NSAID use on greater than 7 of 30 past days, as reported by the patient.
- One of three common low-risk surgical procedures: For this study, the three-common low-risk surgical procedures will include laparoscopic gallbladder removal, inguinal hernia repair, and breast lumpectomy.
Exclusion Criteria:
- Anticipated other surgery within 6 months or anticipated life expectancy of less than 6 months
- Patients with contraindications to NSAID drugs in the NSAID arm, opioid drugs in the OPIOID arm, or acetaminophen will be excluded. There are specific contraindications that will be reviewed per protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: NSAID regimen
Surgical teams will elect for one of the medications within the treatment arm to which the patient is randomized.
|
Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given:
Acetaminophen 1000 mg by mouth every 6 hours around the clock for the first three days after surgery then as needed thereafter (20 doses).
|
Other: Opioid regimen
|
Acetaminophen 1000 mg by mouth every 6 hours around the clock for the first three days after surgery then as needed thereafter (20 doses).
Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 7 days post surgery
Time Frame: 7 days post surgery
|
This is a one question survey in which the worst pain intensity recorded (0-10 being the worst) will be used.
|
7 days post surgery
|
Safety outcome - number and severity of any adverse medication-related symptoms over 7 days post surgery
Time Frame: 7 days post surgery
|
Symptom Checklist will proactively screen patients for reports of adverse events from analgesic medications over the first 7 days post surgery.
|
7 days post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance v1.0 4a questionnaire
Time Frame: 1 month post surgery
|
This is a 4 question survey in which participants will rate statements pertaining to quality of sleep. Participants will also rate sleep quality as very poor (5), poor (4), fair (3), good (2), or very good (1). |
1 month post surgery
|
Clinically important adverse events
Time Frame: 180 days post surgery
|
The study team will review charts for unplanned postoperative clinical interactions related to pain (patient messages, phone calls, non-routine clinic visits related to pain) and emergency room visits, hospitalizations, and 30-day complications after discharge measured using the American College of Surgeons' (ACS) National Surgical Quality Improvement Program (NSQIP) definitions.
|
180 days post surgery
|
Patient Global Impression of Change (PGIC)
Time Frame: up to 1 month after surgery
|
The perception of improvement after treatment will be assessed by the patient global impression of change PGIC (range 0-7).
|
up to 1 month after surgery
|
Quality of Recovery (QoR) 15
Time Frame: 3 days post surgery
|
There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.
|
3 days post surgery
|
Quality of Recovery (QoR) 15
Time Frame: 7 days post surgery
|
There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.
|
7 days post surgery
|
PROMIS Pain Interference 4a
Time Frame: 3 months
|
This is a 4 question survey that assesses the degree to which pain interferes with various aspects of life.
Items are scored on a 1 ("Not at all") to 5 ("Very much") scale with a range of 4 - 20.
Higher scores indicate greater pain interference.
|
3 months
|
PROMIS Preference score 29+2 Profile v2.1
Time Frame: 3 months
|
This is a 31 question survey that includes questions to evaluate each of 7 domains (physical function, anxiety, depression, fatigue, sleep disturbance, social functioning, and pain interference) using a 5- point Likert scale, as well as a single item to assess pain severity on a 0-10 scale as well as 2 questions for cognitive function.
Higher scores are indicative of better health.
|
3 months
|
Substance use based on the Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) tool
Time Frame: 180 days post surgery
|
This National Institute on Drug Abuse (NIDA) TAPS tool has part 1 (5 questions) and part 2 (possible 9 questions).
|
180 days post surgery
|
National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question
Time Frame: 3 months
|
3 months
|
|
National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question
Time Frame: 180 days
|
180 days
|
|
New prolonged opioid use
Time Frame: days 4-180 post surgery
|
This will include greater or equal to 1 opioid prescription post-discharge between 4-180 days post discharge.
|
days 4-180 post surgery
|
Chronic pain based on Brief Pain Inventory (BPI) pain intensity score at 180 days post surgery
Time Frame: 180 days post surgery
|
One question survey in which the participants rate pain intensity recorded (0-10), ten being the worst.
|
180 days post surgery
|
Chronic pain based on Body Map
Time Frame: 180 days post surgery
|
Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.
|
180 days post surgery
|
Acute pain based on The Michigan Body Map
Time Frame: 7 days post surgery
|
Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.
|
7 days post surgery
|
Healthcare Utilization related to pain at 1 month
Time Frame: within 1 months after surgery
|
Participants will answer questions about their healthcare utilization related to pain for the time period from date of surgery to one month later for the following three events: (1) postoperative clinical interactions related to pain in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations.
The study team will also review health record for the same events.
|
within 1 months after surgery
|
Healthcare Utilization related to pain at 6 months
Time Frame: within 6 months after surgery
|
Participants will answer questions about their healthcare utilization related to pain for the time period from date of surgery to six months later related to pain for the following three events: (1) postoperative clinical interactions in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations.
The study team will also review health record for the same events.
|
within 6 months after surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mark Bicket, MD, PhD, University of Michigan
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00215416
- CER-2021C1-22398 (Other Grant/Funding Number: PCORI)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on NSAID
-
Aalborg UniversityCompleted
-
Regional Hospital HolstebroCompleted
-
St. Louis UniversityWithdrawn
-
Yonsei UniversityCompletedMyofascial Pain Syndrome of the Upper TrapeziusKorea, Republic of
-
Kayseri City HospitalCompleted
-
LEO PharmaCompleted
-
Bispebjerg HospitalLundbeck Foundation; The Danish Rheumatism Association; Team Denmark; Danish Ministry... and other collaboratorsCompletedMuscle DamageDenmark
-
Montefiore Medical CenterCompleted
-
Istanbul UniversityCompletedLow Back Pain | Acute PainTurkey
-
Medical University of ViennaMedical Scientific Fund of the Mayor of ViennaUnknownPain, PostoperativeAustria